Ocumension Therapeutics - B Stock: price and insider trades · Hong Kong

Every trade that managers of Ocumension Therapeutics - B disclose to HKEX is tracked on this page. The company sits in the Health Care sector. Between 19 October 2025 and 19 October 2026, 2 insiders published 15 filings.

The record shows 1 purchase on the open market, made by 1 insider, against 7 sales by 2 insiders. No amount is published for 8 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 senior executive.

Across the 736 companies tracked on its exchange, the median is 5 filings; at 15 filings, this issuer sits above that mark. Since 2020, the database holds 10 purchases and 35 sales by insiders of the company.

The clock since the last published purchase (18 June 2026) now reads 129 days. The median gap between a trade and its publication by HKEX is 5 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

Other companies in the same sector with recent insider buying flagged by our signals: Vivos Inc and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.